Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Image-guided Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
EF 2013-14
Résumé
Radiation therapy is administered to approximately 60% of all cancer patients for a wide variety of cancer types. In cancer research, mice bearing cancer are often used as valuable research tools, for example during drug development. However, their small size has presented a challenge to researchers in administering advanced radiation therapy techniques such as SBRT (stereotactic body radiation therapy): precise delivery of a high dose of radiation in a small number of treatment sessions.
By using a newly developed mouse irradiation apparatus called Small Animal Radiation Research Platform (SARRP), I hypothesize that modern radiation therapy techniques, specifically SBRT, can be accurately delivered to mice with cancer. In order to verify the accuracy of radiation therapy for mice, an inanimate structure designed to mimic the physical properties of a mouse will be irradiated under various conditions. The intended pattern and strength of radiation delivered to the structure will subsequently be verified with devices that record radiation dose. The SARRP will then be ready to deliver radiation in real animal experiments.
The subsequent animal radiation therapy experiments are aimed at (1) using medical imaging techniques to characterize how mice with cancer respond to radiation therapy and (2) observing distinct features of SBRT compared to conventional radiation therapy techniques in mice. For the first aim, a nuclear medicine imaging technique called PET (positron emission tomography) will be used along with CT (computed tomography) to characterize the radiation response of tumors in mice. For the second aim, my current interest lies in how SBRT can trigger the body’s immune system to attack cancer cells. It will be investigated by comparing tumor radiation response between mice with and without functional immune system. The animal experiments using SARRP will focus on mice that contain liver cancer, such that the findings will be more applicable to radiation therapy for human liver cancer patients.
Liver cancer is the fifth most common cancer and the second leading cause of cancer death globally. Only about 20% of liver cancer patients can receive surgery, and other forms of treatment such as chemotherapy are ineffective in most cases of liver cancer, which are identified at advanced stages. The effectiveness of radiation therapy in liver cancer has been poorly examined and it is seldom used due to liver toxicity. However, radiation dose to the liver can be significantly reduced with the recent technological advances in radiation therapy.
I will be involved in a project aimed at treating liver cancer patients who have exhausted other treatment options with high dose rate (HDR) SBRT that also accounts for the patients' breathing motion. Specifically, after a large number of patients with otherwise incurable liver cancer are administered HDR SBRT and followed up with medical imaging, I will analyze the tumor responses in the acquired patient images to investigate both the efficacy and the biological mechanism of liver HDR SBRT. The results will be compared with the results of the mouse experiments to arrive at a better understanding of the application of SBRT in liver.
In summary, the establishment of precise radiation therapy for mice with cancer in general can open a new avenue in radiation therapy research. In this case, my mouse experiments with the emphasis on cancer imaging can provide basic biological understanding as well as insights into patient treatment. With the project on patients, I hope to contribute to a new treatment option and a non-invasive monitoring technique for otherwise incurable liver cancer patients. The overall scheme of my work has broad implications from laboratory animal research to patient treatment.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311983
Name
Lee Hwan
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Image-guided Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Hepatocellular Carcinoma; Nuclear Medicine; Oncology; Radiotherapy
Abstract
Radiation therapy is administered to approximately 60% of all cancer patients for a wide variety of cancer types. In cancer research, mice bearing cancer are often used as valuable research tools, for example during drug development. However, their small size has presented a challenge to researchers in administering advanced radiation therapy techniques such as SBRT (stereotactic body radiation therapy): precise delivery of a high dose of radiation in a small number of treatment sessions.
By using a newly developed mouse irradiation apparatus called Small Animal Radiation Research Platform (SARRP), I hypothesize that modern radiation therapy techniques, specifically SBRT, can be accurately delivered to mice with cancer. In order to verify the accuracy of radiation therapy for mice, an inanimate structure designed to mimic the physical properties of a mouse will be irradiated under various conditions. The intended pattern and strength of radiation delivered to the structure will subsequently be verified with devices that record radiation dose. The SARRP will then be ready to deliver radiation in real animal experiments.
The subsequent animal radiation therapy experiments are aimed at (1) using medical imaging techniques to characterize how mice with cancer respond to radiation therapy and (2) observing distinct features of SBRT compared to conventional radiation therapy techniques in mice. For the first aim, a nuclear medicine imaging technique called PET (positron emission tomography) will be used along with CT (computed tomography) to characterize the radiation response of tumors in mice. For the second aim, my current interest lies in how SBRT can trigger the body’s immune system to attack cancer cells. It will be investigated by comparing tumor radiation response between mice with and without functional immune system. The animal experiments using SARRP will focus on mice that contain liver cancer, such that the findings will be more applicable to radiation therapy for human liver cancer patients.
Liver cancer is the fifth most common cancer and the second leading cause of cancer death globally. Only about 20% of liver cancer patients can receive surgery, and other forms of treatment such as chemotherapy are ineffective in most cases of liver cancer, which are identified at advanced stages. The effectiveness of radiation therapy in liver cancer has been poorly examined and it is seldom used due to liver toxicity. However, radiation dose to the liver can be significantly reduced with the recent technological advances in radiation therapy.
I will be involved in a project aimed at treating liver cancer patients who have exhausted other treatment options with high dose rate (HDR) SBRT that also accounts for the patients' breathing motion. Specifically, after a large number of patients with otherwise incurable liver cancer are administered HDR SBRT and followed up with medical imaging, I will analyze the tumor responses in the acquired patient images to investigate both the efficacy and the biological mechanism of liver HDR SBRT. The results will be compared with the results of the mouse experiments to arrive at a better understanding of the application of SBRT in liver.
In summary, the establishment of precise radiation therapy for mice with cancer in general can open a new avenue in radiation therapy research. In this case, my mouse experiments with the emphasis on cancer imaging can provide basic biological understanding as well as insights into patient treatment. With the project on patients, I hope to contribute to a new treatment option and a non-invasive monitoring technique for otherwise incurable liver cancer patients. The overall scheme of my work has broad implications from laboratory animal research to patient treatment.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Hwan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~